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The first immunoglobulin (Ig) chain to be expressed in developing B cells is 
the # chain (1-4). Light (L) 1 chain expression follows and results in the assembly 
of #  and  L  chains to  form IgM  monomers  (#2L2)  (5,  6).  IgM  is secreted as a 
pentamer, (#2L2)5  (reviewed in  7).  The formation of pentameric IgM depends 
on disulfide bonding of one or more secretory ~ chains with another cellular 
component, the J  chain (8-10), and involves the penultimate cysteine residue in 
the U chain terminus (11). 
Whether all  IgM pentamers are structurally uniform is open to question, as 
recalled by an old controversy concerning the number and possible heterogeneity 
of antigen-binding sites in individual IgM antibodies. Reports of 10 equivalent 
antigen-binding sites (12-14) are at variance with reports of 10 nonequivalent 
antigen-binding sites;  i.e.,  5  low and  5  high affinity binding  sites  (15-17).  A 
number of laboratories have reported only 5  binding sites per IgM pentamer 
(18-22).  Some results of less than  10 binding sites may be attributed to steric 
hindrance of antigen binding and/or heterogeneity of IgM antibodies (20,  23, 
24);  however, other results appear  free of this  criticism, particularly those of 
Giles  et  al.  (22)  in  which  two  monoclonal  antidinitrophenyl (anti-DNP)  IgM 
antibodies were shown to display an average of only 5 high affinity binding sites 
for DNP. 
Relevant to possible irregularities in IgM structure and valence, the present 
work  provides  evidence  that  some  #  chains  of secreted  IgM  lack  antigenic 
determinants characteristic of Igh variable regions (Igh-V). The truncated # (u') 
chains have an apparent molecular weight of ~55,000,  display antigenic deter- 
minants  in  common  with  the  u  constant  region  (C/~), and  are  detectable  in 
preparations of specifically purified IgM of different IgM-producing tumors and 
of normal serum  IgM  (a  brief account of these findings was reported earlier 
[25]). u' Chains are also detectable in IgM-producing tumor cells, in a hybridoma 
cell line that lacks a  productive #  allele, and in bone marrow cells of normal 
mice. The possible significance of #' chains is discussed. 
This work was supported by grants AI-13323, CA-04946, and CA-06927 from the National Institutes 
of Health, and by an appropriation from the Commonwealth of Pennsylvania, 
1 Abbreviations used in this paper:  C#, constant region of #  chain; DNP, dinitrophenyl; HBSS, 
Hanks' balanced salt solution; H  chain, heavy chain; IEF, isoelectric focusing; L chain, light chain; 
LPS,  lipopolysaccharide; u',  truncated u;  NP,  (4-hydroxy-3-nitrophenyl)acetyl; PAGE, polyacryl- 
amide gel electrophoresis: PC, phosphorylcholine; SDS, sodium dodecyl sulfate; Tin, tunicamycin; 2- 
ME, 2-mercaptoethanol. 
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Materials and  Methods 
Animals and IgM-producing Tumors.  Pooled serum of normal mice and serum of mice 
bearing IgM-producing plasmacytomas and hybridomas served as sources of IgM. The 
plasmacytomas were  MOPC-104E  (26),  TEPC-183  (26),  and  M104-76  (27).  Three hy- 
bridomas were used: K6100.16 (28), HPCM3, and HPCM27 (29). All of the tumors were 
grown in BALB/c mice except K6100.16, which was grown in (NZB × BALB/c)F~ mice. 
The inbred mouse strains used in this study included BALB/c, C57BL/6, C.B-17, and an 
Ig-deficient mutant of C.B-17 (C.B-17scid)  (30).  All mouse strains were bred and main- 
tained at this Institute. 
Cells.  Bone marrow, spleen, and lymph node cell suspensions of 12-wk-old BALB/c 
mice were made up aseptically in cold Hanks' balanced salt solution (HBSS) containing 
1% bovine serum albumin. Red blood cells were lysed with NH4CI (31).  Nucleated cells 
were counted in a hemacytometer; cell viability was determined by trypan blue exclusion. 
Cultured  cell  lines  included  the  IgM-producing tumors,  M104-76  and  M27,  and  a 
hybridoma (C2) (32) that deleted its productive # allele (33). M27 produces IgM molecules 
that specifically bind phosphorylcholine (PC) (29). All cell lines were grown in RPMI 1640 
(Whittaker M. A. Bioproducts, Walkersville, MD) supplemented with glutamine (2 mM), 
gentamycin (100  #g/ml),  2-mercaptoethanol (2-ME) (5  ×  10  -~  M),  and  20%  fetal calf 
serum (Whittaker M.  A. Bioproducts). This growth medium is hereafter referred to as 
RPMI 1640 medium. 
Cell Incubations.  All incubations were at 37 ° C in an atmosphere of 5 % CO~. Untreated 
cells (controls) were simply incubated in RPMI 1640 medium. Tunicamycin (Tm)-treated 
cells (2-4  ×  106/ml) were incubated 4-6 h  in RPMI  1640  medium containing 5 #g/ml 
Tm (a gift of Dr. Robert Hamill, Eli Lilly Co., Indianapolis, IN). Stimulation of cells (~4 
×  106/ml)  with S.  typhosa 0901  iipopolysaccharide W  (LPS) (Difco Laboratories,  Inc., 
Detroit, MI) was carried out for 48 h in RPMI  1640  medium containing 20 #g/ml LPS. 
For internal labeling of cell proteins, cells were washed twice in HBSS and then incubated 
for 4  h at ~107 cells/ml in RPMI  1640  medium containing 50 #Ci/ml  [35S]methionine 
(New England Nuclear, Boston, MA). 
Cell Lysates and Supernatants.  Cells were washed twice in HBSS and suspended for 20 
min in cold lysis buffer (0.5% Nonidet P-40 [NP-40],  150 mM NaCI,  10 mM Tris-HCl, 
pH 7.4, 0.02%  NAN,,  1 mM phenylmethyisulfonyl fluoride,  10 mg/ml aprotinin [Sigma 
Chemical Co., St. Louis, MO], and  10 mg/ml soybean trypsin inhibitor [Millipore Corp., 
Freehold, NJ]).  Nuclei and debris were removed by centrifugation (10,000 g) for 10 min 
at 4°C. The supernatant was removed, frozen, and stored in liquid nitrogen. 
M27 cell lysates and salt-precipitated [at 50%  saturated (NH4)2SO4] proteins of M27 
cell supernates were specifically enriched for IgM by incubation with PC-Affigel (kindly 
supplied by Dr. A. Feeny, Medical Biology Institute, La Jolla, CA). IgM was specifically 
eluted from the PC-Affigel with PC (10 -3 M). 
Nonspecific Purification of Serum IgM.  Serum Ig was precipitated and washed in 50% 
saturated (NH4)~SO4. The precipitate was dissolved in 0.1  M PO4 (pH 7.4), reprecipitated 
by extensive dialysis against distilled water, washed twice, and again dissolved in 0.1  M 
PO4.  After clarification by centrifugation (5,000 g), the Ig solution was size fractionated 
over a  1 ×  90 cm column of Bio-Gel A  (1.5m,  100-200  mesh; Bio-Rad Laboratories, 
Richmond, CA) using 0.1  M PO4 as the eluting buffer. The IgM fraction, which eluted 
just after the column void volume, was concentrated and  in some cases fractionated a 
second time. 
Specific Purification of Serum IgM.  The tumor IgM proteins of MOPC-104E  (104E), 
K6100.16 (6100),  HPCM3 (M3), and HPCM27 (M27) were specifically purified on the 
basis of their known binding specificities:  104E (14) was precipitated with a 1-3 dextran; 
6100 (28) was precipitated with NP [(4-hydroxy-3-nitrophenyl)acetyl]-conjugated bovine 
serum albumin; and M3/M27 (29) were affinity purified by absorption onto PC-conjugated 
Affigel beads followed by elution  with  l0 -3  M  PC.  These preparations are designated 
104E(dx), 6100(NP),  M3(PC), and M27(PC), respectively. 
Electrophoretic Separation of lgM Heavy (H) Chains.  Polyacrylamide gel electrophoresis 
(PAGE) of reduced IgM subunits in sodium dodecyl sulfate (SDS) was done according to 1864  TRUNCATED u  CHAINS 
Laemmli (34).  Cell  lysates,  cell  supernatant  preparations,  serum,  or  purified  protein 
samples were diluted  in  sample buffer (0.05  M  Tris-HCl, pH 6.8  containing 4%  SDS, 
10% glycerol, and  1% pyronin Y) to twice the desired concentration and then added to 
an  equal  volume of sample buffer containing  0.04  M  dithiothreitol.  All  samples were 
boiled for 5 rain and then loaded onto a 5% polyacrylamide stacking gel (2 cm in length, 
containing 0.1%  SDS in 0.125  M Tris-HCI, pH 6.8).  The separating gel of 7.5 or 10% 
polyacrylamide was 8 cm in length and contained 0.1%  SDS in 0.375  M Tris-HCl, pH 
8.8. The electrolyte buffer (pH 8.8) contained 0.025 M Tris, 0.192 M glycine, and 0.1% 
SDS. Samples were electrophoresed for 2-3 h at constant power (~0.2 W/cm). Prestained 
molecular weight standards (Bethesda Research Laboratories, Gaithersburg,  MD) were 
routinely applied to all gels. 
Two-dimensional gel electrophoresis was according to the technique of O'Farrell (35) 
except for minor modifications in the electrode solutions for isoelectric focusing (IEF). 
The cathode solution consisted of NaOH (0.2 M) and CaO (0.2 M) (to precipitate dissolved 
CO2).  This was  prepared  in  advance,  stored  under  vacuum, and  filtered  immediately 
before use.  The anode  solution  consisted of 0.4  M  aspartic acid and was prepared as 
needed. These modifications greatly reduced "cathode drift" (36) and resulted in a stable 
gradient over a pH range of 3-9,  Samples of purified serum IgM were diluted  in  IEF 
sample buffer (9.2 M urea, 2% NP-40, 2% ampholine [pH 3.5-9.5], 5% 2-ME) and loaded 
on the basic end of tube gels consisting of 6% acrylamide, 15% N,N'-diailyltartardiamide 
(37), 2% NP-40, 2% ampholine (pH 3.5-9.5), and 9.2 M urea. Samples were electropho- 
resed for 5500 volt-hours. Afterwards, the tube gels were equilibrated with SDS sample 
buffer and electrophoresed in a second dimension in 10% acrylamide slab gels. 
Western Blot Analysis.  After gel electrophoresis, the separated proteins were electro- 
phoretically transferred onto nitrocellulose in the manner described by Towbin et al. (38). 
This  was done  for  16-20  h  at  room  temperature  at  constant  current  (60  mA).  The 
electrolyte buffer (pH 8.3) contained 0.125 M Tris, 0.192 M glycine, and 20% (vol/vol) 
methanol. The nitrocellulose blot was subsequently incubated at room temperature with 
inert protein (2% casein in 0.075 M Tris-HCl, pH 7.5) for 3-4 h, then with antibody for 
~25  125  ~25  ~2~  _> 16 h, and finally with  I-labeled IgM of 104E (I-104E) or  I-labeled protein A (  I- 
protein  A) fbr 3  h.  (Proteins were radiolabeled with  ~I  [Amersham Corp,,  Arlington 
Heights, ILl using the chloramine T  method of Hunter [39].) Between incubations, the 
nitrocellulose blot was washed with 0.1  M PO4 buffer (pH 7.4). After the last incubation, 
the blot was again washed and then dried.  A  sandwich of the blot, x-ray film (X-Omat 
AR film; Eastman Kodak, Rochester,  NY), and an intensifier screen  (Du  Pont Cronex 
Lightening-Plus XD; Du Pont Co., Wilmington, DE) was loaded into a film holder cassette 
and exposed at -70 ° C. The film was developed in a Kodak automatic x-ray film developer. 
The autoradiographs are referred to as Western blots. In some instances, the separated 
proteins were not transferred out of the gel, but instead fixed and stained with Coomassie 
Brilliant Blue or with silver nitrate (40). 
Antibodies.  Several independent antisera to mouse IgM were used to visualize IgM H 
chains.  These  included  goat anti-IgM  (Cappel  Laboratories,  Cochranville,  PA),  rabbit 
anti-IgM (Litton  Bionetics,  Inc., Kensington,  MD), and  our own  rabbit anti-IgM. The 
latter was made against BALB/c IgM and absorbed with Sepharose 4-B beads conjugated 
with IgG2a (X) of HOPC-1 (26) and IgG  1 (~) of MOPC-31 c (26). 100 ~1 of a given antisera 
in a  10 ml solution of 0.075 M Tris/2% casein (pH 7.5) contained sufficient antibody for 
successive coating of eight or more nitrocellulose blots, 
Rat monoclonal antibodies specific for # chains (R 1.42.22, R33.24.12, R33.60.2) were 
a gift of Dr. T. Imanishi-Kari (Massachusetts Institute of Technology, Center for Cancer 
Research, Boston,  MA).  Affinity-purified rabbit antibodies (28)  specific for Ig H  chain 
variable regions (antMgh-V) of 6100 or H PC 52 (41) were generously supplied by Dr. K. 
Karjalainen (Basel  Institute for Immunology, Basel,  Switzerland). 
Results 
Detection  of t~'  Chains  in  Secreted  IgM.  Electrophoretic  separation  of  IgM 
subunits in SDS-containing acrylamide gels resolved two distinct sizes of H  chains. MARKS  AND  BOSMA  1865 
FIGURE  ].  SDS-PAGE of reduced IgM subunits resolves two apparent sizes of heavy chain, 
denoted # and ~'. (a) Polyacrylamide gel (I 0%) containing  decreasing quantities of M3(PC) in 
lanes  1-4  (20,  10,  5,  and  2  tzg). Proteins were  stained with Coomassie Brilliant Blue.  (b) 
Polyacrylamide gel (7.5%) containing  purified serum lgM of TEPC-183-bearing BALB/c mice 
(30 #g in lane 5;  15 #g in lane 6) and of normal BALB/c mice (10 ~tg in lane 7). Proteins were 
stained with silver nitrate. 
This is illustrated in Fig.  1 a for the PC-binding IgM of M3. PC affinity-purified 
IgM was reduced, and different concentrations were applied to a  10% gel that 
was subsequently stained with Coomassie Blue. Lanes 1 and 2, containing 20 and 
10 ~g of M3(PC), respectively, show an H  chain band labeled, #'  (-55  kD), in 
addition to the expected ~ and  L  chain bands.  The silver-stained 7.5%  gel of 
Fig.  1 b shows a  similar result for purified serum IgM of normal BALB/c mice 
(lane 7) and of BALB/c mice bearing TEPC-183,  an IgM-producing plasmacy- 
toma (lanes 5 and 6).  Ig L chains are not resolved in a 7.5% gel and they run in 
the  solvent  front.  Note  that  the  relative  intensities  of #'  and  ~  chains  are 
comparable for normal serum IgM but disproportionate for TEPC-183 and M3. 
~' Chains Display C# Antigenic Determinants.  We also detected ~' chains with 
anti-IgM  antibody, as  shown  by Western  blot analysis.  Nitrocellulose blots  of 
acrylamide gels were sequentially overlaid with 2.5% casein, anti-IgM antibody, 
and ~zsI-104E. Representative results are shown in Fig. 2. Two bands correspond- 
ing in size to ~ and ~' chains are clearly seen for reduced IgM samples of TEPC- 
183  (Fig.  2,  lane 3),  M27(PC)  (lane 4),  BALB/c serum (lane 5), and C57BL/6 
serum (lane 6).  Controls  for specificity included Ig-deficient serum of a  C.B- 
17scid mouse (lane 7) and purified mouse IgG (lane 8).  Nonreduced samples of 
TEPC-183 (lane i) and M27(PC) (lane 2) gave only one band at the top of the 
5% stacking gel. 
Serologic detection of ~'  chains was not dependent on a particular anti-IgM 
serum or labeled IgM indicator. In fact, three different monoclonal antibodies 
(R1.42.22,  R33.24.12,  and R33.60.2)  specific for Cu determinants recognized 
~'  chains (see Fig.  3).  Moreover, when isolated  125I-~ chains were eluted from 
acrylamide gels and used as the labeled indicator (in lieu of ~251-104E), the same 1866  TRUNCATED  p  CHAINS 
FIGURE  2.  SDS-PAGE (10%) Western blot overlaid with anti-/~ and  ~51-104E,  showing that 
u' chains display Cp antigenic determinants.  All samples were reduced except in lanes  1 and 
2. (1 and 3) lgM of TEPC-183 (1 pg), (2 and 4) M27(PC)  IgM (0.5 #g), (5), BALB/c serum 
(10 ul diluted 10-2), (6) C57BL/6 serum (5/LI diluted 10-~), (7) C.B-17scid mouse serum (10 
pl diluted 5 x  10-1), and (8) lgG of BALB/c (10/~g). 
FIGURE  3.  SDS-PAGE (7.5%)  Western  blots  overlaid  with  monoclonal  anti-~ (R33.24.12) 
and  ~2~I-104E,  indicating  variable  proportions  of #'  to #  chains  in  lgM of different IgM- 
producing tumors. Each of the four lanes, from left to right in each blot, containing decreasing 
quantities (10, 5.0, 2.5, 1.25 pg) of reduced 104E(dx), M 104-76, BALB]c IgM, and 6100(N P). 
The positions of the molecular mass standards (92, 68, and 43 kD) are indicated between each 
blot. 
results were obtained (data not shown). Thus, we infer that p' and/~ chains share 
similar (if not identical) C~ antigenic determinants. 
Variable  Proportions  of #'  and  tz  Chains  in  Different  IgM  Populations.  To 
estimate  the  proportion  of  IgM  H  chains  corresponding  to  #'  chains,  serial 
dilutions  of  mouse  serum  and  various  IgM  preparations  were  reduced  and 
electrophoresed in 7.5% gels. Nitrocellulose blots of the gels were overlaid with 
monoclonal  anti-t~ (R33.24.12)  and  1251-104E, and  exposed  to  x-ray  film.  By 
superimposing  the  developed  film  over  the  blot,  we  were  able  to  cut  out 
nitrocellulose strips corresponding to radioactive bands of #'  and ~. The strips 
were counted in a gamma counter, and the percentage of counts (cpm) associated MARKS AND  BOSMA  1867 
FIGURE 4.  Evidence that #' chains lack Igh-V determinants.  Duplicate halves of an SDS- 
PAGE (7.5%) Western blot overlaid (a) with rabbit anti-u and l~SI-protein A and (b) with 
affinity-purified rabbit anti-6100 Igh-V and l*SI-protein A. All samples were reduced. (Lane 
1) 10 #g of IgG2a (~,) (from HOPC-1); (2) 5 #g of M3(PC) IgM; (3) l0 #g of 104E IgM; (4) 5 
#g of TEPC-183 IgM; and (5) 2 #g of 6100(NP) IgM. The positions of the molecular mass 
standards (92, 68, and 43 kD) are indicated to the right of lane 5. 
with the #'  band  was calculated from the relationship:  [cpm ~t'/(cpm ~t'  +  cpm 
u)]  x  100. 
In Fig. 3, we show the autoradiographs of four such titrations. As can be seen, 
#'  chains  were  barely detectable  in  IgM  of MOPC-104E  (<1%)  and  relatively 
low amounts were in the IgM of M 104-76 (_<5%). In contrast, #' chains accounted 
for ___30% of the H  chains in the normal serum  IgM and for -50%  in the IgM 
of 6100.  A  strictly quantitative  interpretation  of these  results,  however,  is  not 
possible as the  125I cpm associated with #'  (or #) chains was not linearly related 
to  the  concentration  of  IgM  added  to  the  gel  (slope  of  log2  cpm  vs.  log2 
concentration  of IgM  =  0.6-0.7).  Moreover,  the  implicit  assumption  in  these 
analyses that monoclonal anti-# binds to #'  and #  chains with  the same stoicbi- 
ometry and affinity is unproven. 
The  estimated  yield  of L  chains  relative  to  IgM  H  chains  was  reasonably 
constant for all preparations and independent of wide variations in the estimated 
proportion of ts'  chains.  This conclusion is based on an  analysis similar to that 
above except that for this we used anti-L chain-specific antisera and the appro- 
priate  *25I-labeled  indicator (data  not  shown).  This suggests  that  L  chains  are 
able to associate with ~' chains. 
~' Chains Lack Igh-V Antigenic Determinants.  To test for the presence of Igh- 
V determinants on #' chains, affinity-purified anti-Igh-V sera and anti-# antibody 
were applied separately, to duplicate bzlves of a given nitrocellulose blot contain- 
ing a  panel  of reduced  Ig  proteins.  An  appropriate  lzSI-labeled  indicator  was 
subsequently added  to each  blot.  Figs.  4  and  5  show the results obtained with 
two anti-Igh-V sera,  anti-Igh-V6100  and anti-Igh-V  HPC  52.  Neither of these 
antisera reacted with/~'  chains,  although  they did recognize the #  chains of all 
but two IgM preparations. Anti-lgh-V6100 crossreacted with # chains of TEPC- 1868  TRUNCATED  ~ CHAINS 
FIGURE 5.  Evidence that ~z' chains lack lgh-V determinants. Duplicate halves of an SDS- 
PAGE (7.5%) Western blot overlaid (a) with rabbit anti-# and l~I-protein A and (b) with 
affinity-purified  anti-HPC-52 Igh-V and 1~SI-protein A. All samples were reduced. (Lane 1) 
20 ug of BALB/c IgG; (2) 30 t~g of TEPC-183 IgM; (3) 30 ug of M3(PC) IgM; and (4) 10 p.g 
of BALB/c IgM. The positions of the molecular mass standards (92, 68, and 43 kD) are 
indicated to the right of lane 4. 
183 and MOPC-104E  (Fig. 4b, lanes 3 and 4) but not with those of M3 (lane 2). 
Similarly, anti-Igh-V HPC 52 showed a detectable crossreaction with t~ chains of 
TEPC-183 and M3 (Fig. 5b, lanes 2 and 3) but not with ~ chains of normal IgM 
of BALB/c mice (lane 4). These results clearly demonstrate the Igh-V specificity 
of the antisera and the apparent absence of Igh-V determinants on #' chains. 
Two broadly reactive anti-Igh-V sera (anti-Igh-V 104E and anti-Igh-Vnp) (28) 
also failed to reveal t~' chains (data not shown). Therefore, we infer that #' chains 
are missing Igh-V determinants and probably all of the variable region. Consist- 
ent with this inference is the restricted charge heterogeneity of #'  chains. This 
was  demonstrated  by  two-dimensional  gel  analysis  of  serum  IgM  of normal 
C57BL/6  mice.  IgM  subunits were subjected to  IEF in  one dimension and to 
SDS-PAGE (10%) in the second dimension. Western blot analysis of the gel (with 
anti-# and ~251-104E) showed ~' chain banding from pH 5.5 to 6.0, whereas that 
of u chains extended from pH 5.5 to 7.8 (Fig. 6). 
Detection of Intracellular #' Chains.  Low levels of intraceilular #' chains were 
detected in both  of the  IgM-producing tumors examined,  M104-76  and M27. 
Results are shown only for the M27 cell line with the molecular mass (kD) of tz' 
and #  chains indicated in parenthesis (Fig.  7).  M27  cell lysates, prepared  from 
cells that had been  incubated 4  h  in medium containing unlabeled methionine 
or  labeled  [35S]methionine,  were  specifically enriched  for  IgM  by  adsorption 
onto  PC-Affigel, followed by  elution  with  PC  (10 -3  M).  Both  polyclonal and 
monoclonal anti-/~ readily detected /~(78) and ~z'(55)  chains in  this material,  as MARKS  AND  BOSMA  1869 
FIGURE 6.  Western blot of two-dimensional gel of reduced C57BL/6 IgM showing restricted 
charge heterogeneity of It' vs. # chains. To serve as marker for # and ~t' chains, purified 6100 
IgM (10 tzg) was added at the alkaline end of the IEF tube gel before electrophoresis in SDS- 
containing polyacrylamide (10%).  The nitrocellulose blot was overlaid with antiqt and  125I- 
104E. The positions of the molecular mass standards (92, 68, and 43 kD) are indicated on the 
left. 
FIGURE 7.  SDS-PAGE (10%)  blots of reduced and  nonreduced  M27(PC)  cell lysate and 
medium. (a) Nonreduced (lane 1) and reduced (2) M27(PC)  lysate from 2 ×  107 ceils labeled 
with [sSS]methionine.  (3 and 4) Reduced cell lysate from unlabeled cells overlaid with anti-u/ 
1251-104E and with monoclonal anti-# (R33.24.1)/125I-104E,  respectively. (b) Nonreduced (lane 
5) and reduced (6) M27(PC)  medium of [3~S]methionine-labeled  cells. (7 and 8) Overlaid with 
anti-u/1251-104E and containing reduced M27(PC)  medium of unlabeled ceils (2 ×  107) and 
reduced serum-free medium of M27  cells, respectively. The positions of the molecular mass 
standards (92, 68, and 43 kD) are indicated between lanes 4 and 5. 
shown  by Western  blot analysis (Fig. 7,  lanes 3  and  4).  In addition, a  blot of the 
internally  labeled  polypeptides  of  [~SS]methionine-labeled  cells  showed  bands 
corresponding  to  u(78)  and  ~'(55)  chains  (Dane 2);  neither  of these  bands  were 
detected  in  lane  1  containing the  unreduced  sample.  Clearly, t~'(55) accounted 1870  TRUNCATED  u  CHAINS 
FIGURE 8.  SDS-PAGE  (10%) Western blot of cell lysates  from the C2 cell line. The blot was 
overlaid with anti-/~/l~Sl-104E. (Lane 1) Reduced C2 lysate; (2) reduced lysate of Tin-treated 
C2 cells; (3) nonreduced C2 cell lysate; and (4) reduced BALB/c serum. The positions  of the 
molecular mass standards (92, 68, 43, and 25 kD) are indicated to the right of lane 4. 
for only a  small proportion (~5%) of the recently synthesized intracellular IgM 
H  chains.  None of the recently synthesized U'(55)  chains could be detected in 
the PC affinity-purified IgM of the cell medium (Fig. 7, lane 5). Note, however, 
that the cell medium of the unlabeled control cells did in fact contain secreted 
u'(55) chains (Fig. 7, lane 7) as detected by Western blot analysis; ~'(55) chains 
were also detected in serum-free medium of M27 cells (lane 8) (defined serum- 
free medium [42] was kindly supplied by Dr. D. Mosier, Medical Biology Institute, 
La Jolla, CA). 
Truncated u  chains were also detected in a hybridoma cell line (C2) lacking a 
productive # allele (33) (Fig. 8, lane 1). The size of the C2 u' chains [•'(53)]  was 
slightly smaller than that of M27 but equivalent to that of bone marrow cells, as 
shown  later.  However,  unlike  bone  marrow  cells,  C2  cells  failed  to  produce 
detectable unglycosylated ~'  chains in the presence of Tm (Fig. 8, lane 2); also, 
the  ~'  chains of C2  were  apparently not  crosslinked by disulfide bonds  since 
their migration of SDS-PAGE was unaffected by the presence or absence of DTT 
(Fig. 8, lane 1 vs. 3). 
Tissue-specific  Differences  in  the  Production  of U'  Chains.  Western  blots  of 
normal bone marrow cell lysates showed a prominent ~'(53) band in addition to 
that of ~(76) (Fig. 9a, lane 2).  Incubation of bone marrow cells in tissue culture 
medium for 6  h  (Fig. 9 a, lane 3) resulted in the faint appearance of ~(80) and 
u'(57) chains as well. After 48 h incubation, the u(80) and u(76) bands were each 
of comparable  intensity, as were the/~'(57)  and u'(53)  bands (Fig.  9b,  lane 9). 
Inclusion of LPS in  the medium during the  48  h  incubation did not alter the 
result (Fig.  9b,  lane  10).  In  the presence  of Tm,  bone marrow cells produced 
substantial quantities of unglycosylated t~ [-t~(62)] and ~' [-/~'(42)]  chains (Fig. 9 a, 
lane 4); interestingly, t~'(53) was no longer detectable, suggesting a fast turnover 
of u'  chains in bone marrow cells (Fig.  9a,  lane 4).  This contrast differs from 
our results with Tm-treated C2  cells, which contained/~'(53) but no detectable 
-~'(42) (see Fig. 8, lane 3). Also, unlike C2 ceils, the ¢~'(53) chains in bone marrow MARKS  AND  BOSMA  1871 
FI~URE  9.  SDS-PAGE (I 0%) Western blots of reduced bone marrow and spleen cell lysates 
of BALB/c mice. Blots a  and b were overlaid with anti-tlp~sI-104E. The lysates in each lane 
were from: C2 cells (•);  fresh bone marrow cells (2); bone marrow cells incubated for 6  h  in 
the absence (3) or presence (4) of Tm;  spleen cells incubated for 6  h  in  the absence (5) or 
presence (6) of Tin; spleen cells incubated for 48 b  in the absence (7) or presence (8) of LPS; 
bone marrow cells incubated for 48 h  in the absence (9) or presence (10) of LPS. Celt viability 
(73-87%) remained reasonably constant throughout the incubation period for all cell prepa- 
rations.  The  positions of the  molecular  mass standards  (92,  68,  and  43  kD)  are  indicated 
between lanes 6 and 7. 
cells were disulfide bonded (presumably with #  chains)  so that  their  separation 
in SDS-PAGE required reduction (data not shown). 
In striking contrast to bone marrow cells, spleen cells that were incubated for 
6  h  in  RPM1  1640 medium  contained  little or no detectable/~'  chains despite 
the production  of relatively large quantities  of ~(80) and ~(76) chains  (Fig.  9a, 
lane 5).  Similar results were obtained for nonincubated spleen and lymph node 
cells (data not shown) and for spleen cells incubated 48 h,  with or without LPS 
in the medium (Fig. 9b, lanes 7 and 8). Spleen cells incubated in the presence of 
Tm  for 6  h  showed only one species of unglycosylated/~ chain  [-~(62) chains] 
(Fig. 9, lane 6). 
Quantitation  of the radioactivity associated with the u'(53),  u(76), and u(80) 
bands of several Western blots of bone marrow, spleen, and lymph node lysates 
showed that ~'(53) chains accounted for ___30% of the detected IgM H  chains in 
bone marrow vs.  _< 1% of IgM H  chains in spleen and in lymph node cells. This 
analysis was done as described for Fig. 3. 
Discussion 
The preceding results indicate the presence of ~'  chains in serum IgM,  IgM- 
producing  tumor  cells,  and  in  normal  bone  marrow  cells.  In  the  following 
discussion  we consider  (a)  the  evidence  that  #'  chains  are  in  fact truncated  # 
chains  lacking  variable regions;  (b) the  possible basis of/~'  chains;  and  (c) the 
implications of U' chains for the valence of IgM. 
Evidence that ~'  Chains Are Truncated ~ Chains.  #' Chains were serologically 
detected by Western  blot analysis:  nitrocellulose  blots of SDS-PAGE gels con- 
taining  reduced  IgM  were  overlaid  sequentially  with  anti-#  and  ~esI-IgM  of 1872  TRUNCATED  #  CHAINS 
MOPC-104E.  Detection  of antigen  by  this  procedure  depends  on  antibody 
crosslinking  of labeled antigen  (reference antigen)  to the bound antigen.  This 
requires  high  affinity antibodies and  close homology between  the  crosslinked 
antigens, as shown previously in this laboratory (43, 44) with polystyrene as the 
solid phase absorbent. Crossreactions between low affinity antibodies and unre- 
lated  antigens  are  not  measured.  Using  the  above procedure,  #'  chains  were 
found in secreted IgM and in cell lysates of IgM-producing cell lines, but not in 
purified preparations of IgG nor in serum of IgM-deficient C.B-17scid mice (30). 
Further,  #'  chains were detected by three  independent  monoclonal  antibodies 
specific for C# determinants.  We conclude that #' chains have Cu determinants 
in common with ~ chains and are produced by IgM-synthesizing cells. 
A second indication that #' chains are truncated t~ chains was their association 
with specifically purified IgM molecules. Since #' chains appeared to lack variable 
regions (as discussed below), the copurification of #' and/s chains would not be 
expected  unless both were part  of the  same molecule.  Further,  when  affinity- 
purified IgM was not reduced, #' chains were not detected in the separating gel. 
This suggests that # and #' chains are linked together by disulfide bonds. 
Evidence that #' Chains Are Missing Variable Regions.  Antisera specific for Igh- 
V antigenic determinants  failed to react with #' chains.  Four distinct anti-Igh-V 
sera were tested: antMgh-V6100, anti-Igh-V HPC 52, anti-Igh-V104E, and anti- 
Igh-Vnp.  The first three antisera  were made against purified Igh-V fragments, 
affinity purified, and shown to be specific for Igh-V determinants  (28). In all of 
the examples in which the # chains of a given IgM-producing tumor reacted with 
a particular anti-Igh-V sera, the corresponding #' chains were unreactive. From 
this we infer #' chains are lacking variable regions.  Consistent with this, #' and 
chains from serum IgM of normal  mice showed striking differences in charge 
heterogeneity;  #'  chains  displayed  very  little  charge  heterogeneity  compared 
with  that  of #  chains  (see Fig.  6).  This  too indicates  #'  chains  lack a  variable 
region since charge heterogeneity of a given class of Ig chains primarily reflects 
variable region diversity (45). 
Possible Basis for #'  Chains.  The  proportion  of #'  to #  chains varied widely 
according to the particular  source of IgM H  chains.  For example, _>30% of the 
H  chains  in  secreted IgM of normal  mice corresponded to u'  chains  [cpm ~'/ 
cpm #'  +  cpm #) x  100] whereas,  for most IgM-producing  tumors,  this  value 
was -<5%.  Intracellular #' chains generally accounted for _>30% of the detected 
IgM H  chains in bone marrow lysates as opposed to -< 1% in spleen lysates. 
Differences in the proportion of #' to # chains could represent the extent of # 
chain breakdown into #' chains.  If true,  intracellular  proteases would be impli- 
cated since #'  chains were shown to be present  in serum-free medium of M27 
cells.  Moreover,  the  activity of such proteases would have to be under  tissue- 
specific control  to account for the prevalence of #'  chains in  bone marrow  vs. 
spleen cells. Evidence for protease degradation of # chains in bone marrow pre- 
B cells was recently reported by Thorens et al.  (46).  These investigators noted 
that  most # chains were degraded  into a #  fragment of ~48  kD when cell lysis 
was performed in the absence of protease inhibitors.  However, our results with 
lysates of unfractionated bone marrow cells differ from theirs in that we detected 
#' chains in the presence of protease inhibitors and in quantities comparable to MARKS AND  BOSMA  1873 
those of conventional-size # chains. Moreover, our detection of #' chains in the 
C2 cell line suggests that they are not breakdown products of # chains. The C2 
cell line deleted its productive u  allele (33) and could not have synthesized u 
chains; indeed, none were detected. Thus, we are led to consider that #' chains 
may derive from a truncated species of ~t mRNA. 
Evidence consistent with this latter possibility is the recent finding (47) that 
some  pre-B  cells  transformed by  Abelson  murine  leukemia  virus  (A-MuLV) 
contain mRNA transcripts that encode truncated tt chains. Analysis of many A- 
MuLV-transformed cell lines has indicated that the joining of diversity (D) and 
heavy  chain joining  region  (J.)  gene  segments  represents  the  first Igh  gene 
rearrangement in pre-B cells (48), and that most D gene segments have upstream 
initiation  sites  such  that  in-phase joining  of D  and Jn  results  in  synthesis  of 
truncated u chains (D# proteins) (47). Dtt proteins contain a variable DJ, peptide, 
four C# domains, and att secretory (#~) or # membrane (#.) terminus; secondary 
joining of a V gene to the DJ. complex (productive or nonproductive) may result 
in the loss of D# protein synthesis (47). 
The question arises whether productive CU RNA transcripts may be included 
in the class of Cu RNA known as Stt-RNA (for sterile). Various sizes of Stt-RNA, 
1.9-3.0 kb, have been reported in pre-B, B, T, and other cell types (33, 49-51). 
S#-RNA  occur independently of productive #  mRNA (49) and may originate 
from unrearranged tt loci (51). S#-RNA lack Igh-V sequences (49, 51) and appear 
not to be translated into CU protein (52).  Our findings, however, indicate that 
some S#-RNA may in fact encode #'  chains. Western blot analysis of cell lysate 
from the C2 cell line, which has deleted its productive ~t allele and contains only 
the so-called S#-RNA,  showed detectable #'  chains (Fig.  8).  This is consistent 
with previous findings (33) indicating that Su-RNA in the 70Z/3,  38C-13,  and 
C2 cell lines have different possible initiation sites, one of which is located ~0.3 
kb upstream of the DQ52 gene segment. Also, Stt-RNA show the same regulated 
termination at tts or #m polyadenylation sites as do productive #-mRNA (33, 49, 
51). In the case of the C2 cell line, all the S# RNA terminate at the tts site (33), 
consistent with the idea that #'(53) corresponds to an incompletely glycosylated 
#'s chain. 
Implications of#' Chains  for IgM Valence.  The presence of u' chains in serum 
IgM  implies  that  many IgM  antibodies  have fewer antigen-binding sites than 
theoretically  predicted.  Relevant  to  this  point  are  many  conflicting  reports 
concerning the valence of IgM  molecules.  First,  it  has long been known that 
reductive 7 S subunits of IgM antibodies (H2L2) appear univalent; i.e., they bind 
but  do  not  crosslink  antigen  (as  reviewed in  reference 7).  Indeed,  the  first 
reported measurements of the valence of IgM indicated there were about five 
antigen-binding sites per IgM molecule and about one binding site per reductive 
7S subunit (15). One study noted that only 50% of the reductive haifmers (HL) 
of IgM  anti-Forssman  antibody  would bind  antigen  (19).  Some early reports 
suggested there were 10 nonequivalent antigen-binding sites per IgM pentamer 
(16-18); i.e., 5 high-affinity binding sites (106 to 107 liters/mol) and 5 low-affinity 
binding sites (104 to  105 liters/mol). Other reports (12-14) described 10 equiv- 
alent binding  sites for each  IgM  pentamer; interestingly, in  the cases studied 
therein, the binding affinities were relatively low (~ 104 liters/mol). While some 1874  TRUNCATED  t~  CHAINS 
examples of <10 (equivalent) binding sites may be attributed to steric hindrance 
of antigen  binding  and/or  heterogeneity  of IgM  antibodies  (23,  24),  other 
examples appear  free of this  criticism.  This  is especially true  in  the  case of a 
recent report  (22) that  two independent  populations  of monoclonal  IgM anti- 
bodies specific for DNP each contained an average of only one antigen binding 
site per IgM monomer. 
The apparent inconsistencies between the above-mentioned reports may reflect 
variations  in  individual  IgM  populations.  For  instance,  we  estimated  IgM  of 
MOPC-104E to have <1%  of its H  chains as #'  chains.  This  is consistent with 
previous data showing each  IgM pentamer  of 104E to  have  10  homogeneous 
binding sites (14).  Further,  H  chains of the  104E IGM have been isolated and 
sequenced, and no truncated # chains were noted (1 I). In contrast to the  104E 
results, the estimated percentage of ~'  H  chains in serum IgM of normal mice 
was ->30%.  This suggests that many IgM subunits contain a  pair of u-t~' chains 
and only one high affinity antigen-binding site, consistent with a number of the 
reports cited above. 
Whether  truncated  #  chains  are  of any  functional  consequence  to  B  cell 
differentiation  is,  of course,  open  to  debate  (47,  53).  The  mere  existence  of 
intracellular #' chains and their prevalence in normal bone marrow cells suggests 
a possible regulatory role in early B cell development. However, as pointed out 
elsewhere (53), u' chains need not serve an obligate role in B cell development 
since their synthesis is not a prerequisite for productive VDJnjoining (54), which 
in most plasmacytomas and hybridomas appears to occur on ~ alleles, with the 
primary DJ. join not in phase (55-57). 
While t~' chains may not significantly affect the function of secreted pentameric 
IgM, they could affect the ability of antigen to crosslink monomeric IgM on the 
cell surface.  In addition  to u'(53) chains,  we detected the appearance of U'(57) 
chains  in  bone  marrow  cells  after  their  in  vitro  incubation  in  tissue  culture 
medium for ->24 h (see Fig. 9 a, lane 6). The latter could correspond to truncated 
#,~  chains.  Accordingly,  some B  cells may insert  a  high  proportion  of g-/.t'-L2 
molecules on their surface. This would mean relatively few divalent IgM mole- 
cules and less efficient cross-linking of IgM by antigen; this might render affected 
B  cells less  responsive  (or unresponsive)  to antigen  activation.  One is left with 
the enigma of how IgM molecules containing/~'  chains ever get to be secreted 
at all. These and other issues concerning the basis and significance of #' chains 
remain to be resolved. 
Summary 
Secreted IgM was shown to contain truncated #  (~') chains with an apparent 
molecular mass of ~55 kD. The estimated percentage of IgM heavy (H) chains 
in the ~' form ranged from _<1% in the case of one tumor IgM protein (104E) 
to ___30% in normal serum IgM. Serum ~' chains lacked antigenic determinants 
characteristic of immunoglobulin  variable regions and showed a  restricted isoe- 
lectric focusing pattern compared with that of conventional ~ chains. Intracellular 
~' chains were readily detected in bone marrow cells but not in spleen or lymph 
node cells; ~'  chains were also detected in  IgM-producing tumor cells and in a 
hybridoma  cell  line  that  deleted  its  productive ~  allele.  These  results  predict MARKS AND  BOSMA  t875 
irregularities  in  IgM  structure  and  recall  an  old  controversy concerning  the 
valence of IgM molecules. 
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